References
Bartlett JG, Gilbert DN, Spellberg B 2013: Seven ways to preserve the miracle of antibiotics. Clinical infectious diseases 56(10): 1445-1450.
Bauer A 1966: Antibiotic susceptibility testing by a standardized single disc method. American Journal of clinical pathology 45: 149-15
Blot SI, Vandewoude KH, Hoste EA, Colardyn FA 2002: Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Archives of Internal Medicine 162(19): 2229-2235.
Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V 2000: Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 407(6802): 340-348.
Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al. 2003: Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. New England journal of medicine 348(14): 1342-1347.
Golkar Z, Bagasra O, Pace DG 2014: Bacteriophage therapy: a potential solution for the antibiotic resistance crisis. The Journal of Infection in Developing Countries 8(02): 129-136.
Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S 1998: Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. Jama 279(8): 593-598.
Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover F 1997: Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. The Journal of antimicrobial chemotherapy 40(1): 135-136.
Holden HM 1984: Molecular Structure of Kanamycin Nucleotidyl transferase Determined to 3.0-A Resolution. Biochemistry 1993(32): 11977-11971.
Hussain FM, Boyle-Vavra S, Bethel CD, Daum RS 2000: Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. The Pediatric infectious disease journal 19(12): 1163-1166.
Johnson AP, Aucken HM, Cavendish S, Ganner M, Wale MC, Warner M, 2001: Dominance of EMRSA-15 and-16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). Journal of Antimicrobial Chemotherapy 48(1): 143-144.
Lushniak BD 2014: Antibiotic resistance: a public health crisis. Public Health Reports 129(4): 314-316.
Mendem SK, Gangadhara TA, Shivannavar CT, Gaddad SM 2016: Antibiotic resistance patterns of Staphylococcus aureus: A multicenter study from India. Microbial pathogenesis 98: 167-170.
Menichetti F 2005: Current and emerging serious Gram-positive infections. Clinical Microbiology and Infection 11: 22-28.
Michael CA, Dominey-Howes D, Labbate M 2014: The antimicrobial resistance crisis: causes, consequences, and management. Frontiers in public health 2: 145.
Nature E 2013: The antibiotic alarm. Nature 495(7440): 141.
Pierzchala E, Ramos P, Pilawa B 2019: EPR study of free radicals formed in fusidic acid and neomycin under UV irradiation. Acta Poloniae Pharmaceutica-Drug Research 76(2): 215-223.
Read AF, Woods RJ 2014: Antibiotic resistance management. Evolution, medicine, and public health 2014(1): 147.
Reiner K 2010: Catalase test protocol. American society for microbiology: 1-6.
Rossolini G, Arena F, Pecile P, Pollini S 2014: Update on the antibiotic resistance crisis. Clin Opin Pharmacol.18: 56–60.
Ventola CL 2015: The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and therapeutics 40(4): 277.
Viswanathan V 2014: Off-label abuse of antibiotics by bacteria. Gut microbes 5(1): 3-4.
Zhanel GG, Calic D, Schweizer F, Zelenitsky S, Adam H, Lagacé-Wiens PR 2010: New lipoglycopeptides. Drugs 70(7): 859-886.